Award
National Institute of Neurological Disorders and Stroke 1R01NS146509-01
Mechanism of alpha5 integrin contribution to Amyotrophic Lateral Sclerosis pathology
Recipient
Oregon Health & Science University
Award Amount
$615,186.00
Ceiling
$615,186.00
Awarded
April 01, 2026
Identifier
1R01NS146509-01
Research project awarded to Oregon Health & Science University to study the role of alpha5 integrin in ALS pathology and develop therapies, funded by NINDS with an award amount of $615,186.
Description
The project focuses on the role of α5 integrin in ALS pathology, involving genetic models and human iPSC-derived cellular systems to develop immunomodulatory therapies for ALS. The project is led by Dr. Bahareh Ajami at Oregon Health & Science University and funded by the National Institute of Neurological Disorders and Stroke (NINDS).